JAMES MAISEL, MD
Retina Group of New York
In-Person Visits
Ophthalmology
Locations + Appointments
In-Person | $250
About JAMES MAISEL, MD
Dr. Maisel, founder of the Retina Group of New York, is a Board Certified ophthalmologist who completed the Dyson fellowship in Vitreous and Retinal surgery at New York Presbyterian Hospital-Cornell Medical Center. He has received a Special Congressional Award for his work in diabetic retinopathy and the Banko Gift of Sight Award. He also was named the Juvenile Diabetes Research Foundation Humanitarian of the year.
He has served as a Corporate Advisory Board member for the Foundation of the American Academy of Ophthalmology (AAO) and the Juvenile Diabetes Foundation Medical Advisory Board. He was also a member of the AAO Instrument and Device and Low Vision Committees and has received research grants from the U.S. Public Health Service and the National Institute of Health. Dr. Maisel represented the National Society to Prevent Blindness at the ANSI Z-80 committee where he helped establish many ophthalmic industry standards. He served as an editor of EyeCare Technology Magazine and co-editor of Diabetes Technology Magazine. He also authored numerous professional journal articles, and lectures nationally on retina, medical informatics and practice management topics. In addition, he has been a clinical investigator, consultant, educator, and advisory board member for Pfizer, Novartis, Genentech, Alimera, Regeneron and Allergan, educating retinal specialists across the US.
Education
Board Certified Ophthalmologist
Dyson Vitreoretinal Fellowship, New York Presbyterian-Cornell Medical Center
Residency in Ophthalmology, Nassau University Medical Center
Internship in Internal Medicine, Beth Israel Medical Center
Doctor of Medicine, New York Medical College
B.A., Honors Chemistry, Kenyon College
He has served as a Corporate Advisory Board member for the Foundation of the American Academy of Ophthalmology (AAO) and the Juvenile Diabetes Foundation Medical Advisory Board. He was also a member of the AAO Instrument and Device and Low Vision Committees and has received research grants from the U.S. Public Health Service and the National Institute of Health. Dr. Maisel represented the National Society to Prevent Blindness at the ANSI Z-80 committee where he helped establish many ophthalmic industry standards. He served as an editor of EyeCare Technology Magazine and co-editor of Diabetes Technology Magazine. He also authored numerous professional journal articles, and lectures nationally on retina, medical informatics and practice management topics. In addition, he has been a clinical investigator, consultant, educator, and advisory board member for Pfizer, Novartis, Genentech, Alimera, Regeneron and Allergan, educating retinal specialists across the US.
Education
Board Certified Ophthalmologist
Dyson Vitreoretinal Fellowship, New York Presbyterian-Cornell Medical Center
Residency in Ophthalmology, Nassau University Medical Center
Internship in Internal Medicine, Beth Israel Medical Center
Doctor of Medicine, New York Medical College
B.A., Honors Chemistry, Kenyon College
Board Certifications
American Board of Ophthalmology
Hospital Affiliations
Nassau Univeristy Medical Center
Northwell Syosset; Northwell Manhasset
Locations